Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Document › Details

AB Sciex (d/b/a Sciex). (3/11/16). "Press Release: Sciex Announces US HUPO Workshop – New Innovations Towards Industrialized Proteomics".

Region Region Boston, MA
  Country United States (USA)
Organisations Organisation AB Sciex (Danaher, Framingham, MA)
  Group Danaher (Group)
  Organisation 2 Pressure BioSciences Inc. (OTCQB: PBIO)
Products Product mass spectrometer
  Product 2 proteomics
Index terms Index term Danaher–Pressure BioSciences: pressure cycling technology, 201601– collab excl co-marketing of PCT with SWATH acquistion + Sciex MS systems
  Index term 2 Danaher–Advaita: bioinformatics, 201509– distribution excl reseller agreem for iPathwayGuide via OneOmics platform
Persons Person Cafazzo, Mark (Danaher 201601 Director Academic + Clinical Research Business at Sciex)
  Person 2 Olson, Andrew (Advaita Corp 201603 VP Business Development)

SCIEX Seminars Will Focus on Using Industrialized Omics to Perform the Translational Research Needed to Enable Precision Medicine


SCIEX, a global leader in life science analytical technologies announced today an exciting precision medicine workshop to take place at US HUPO on "New Innovations Towards Industrialized Proteomics." Join representatives from SCIEX, Pressure Biosciences, Inc. (PBI) (OTCQB: PBIO), and Advaita Bioinformatics, as they share insightful examples of how SCIEX next-generation solutions are enabling life science researchers and scientists to unlock the potential of their discoveries using industrialized omics to enable precision medicine. The workshop will showcase examples of how SCIEX next-generation mass spec based solutions provide the ability to industrialize the omics research workflows.

Life Science researchers who are striving to transition from basic research to translational research will receive information about providing sample to biology solutions, accelerating and facilitating the biomarker research pipeline, from discovery, validation to translation into biologically and clinically relevant knowledge.

The workshop’s seminars include:

> Next-generation Solutions to Industrialize Proteomics Studies and Advance Precision Medicine

— Mark Cafazzo, Director of Academic Business at SCIEX leads a practical discussion on new technologies for enabling reproducible and biologically meaningful results from proteomics experiments across very large sample cohorts in effort to Industrialize Proteomics.

> From PCT-HD to SWATH® Data Acquisition in Half a Day
— Vera Gross, PH.D., Senior Scientist at Pressure Biosciences, Inc. presents Advances of quantitative SWATH-MS technology with the new introduction of sample QC kits and sample preparation techniques.

> Overview of iPathwayGuide for Next-Gen Proteomics
— Andrew Olson, VP of Business Development at Advaita Corporation discusses a case study whereby a meta-analysis with RNAseq transcript data is aligned with next-gen proteomics data for biological pathway knowledge, a cloud-enabled bioinformatics platform known as iPathwayGuide.


Mark Cafazzo, Director Academic Business, SCIEX
Vera Gross, Ph.D., Senior Scientist, Pressure, Biosciences, Inc
Andrew Olson, VP of Business Development, Advaita Corporation


Tuesday, March 15, 2016
12:15 PM – 1:45 PM EST


Westin Waterfront Hotel
425 Summer Street, Boston, MA, Commonwealth C

An audio recording will be made available after the conference, please contact SCIEX’s media contact for access.

Media Contact

Reporters, editors, and analysts interested in schedule interviews can contact:
Patrick Farrell
Sniper Public Relations on Behalf of SCIEX


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit

SCIEX social: @SCIEXnews, LinkedIn, and on Facebook.

For research use only. Not for use in diagnostic procedures. RUO-MKT-12-2422

AB Sciex is operating as SCIEX.
© 2015 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.


About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.

About Advaita Bioinformatics

Advaita Bioinformatics is a leader in the development of analytic solutions for high-throughput biological data. Founded in 2005 with headquarters near Ann Arbor, Michigan, Advaita’s novel analysis helps translate the terabytes of genomic data produced as a result of gene-expression and protein-expression experiments into a better understanding of the underlying biological phenomena. Advaita’s patented approach, called Impact Analysis, delivers results and insights that cannot be achieved with any other commercial analysis software. iPathwayGuide is the first web application capable of identifying mechanisms of action, micro-RNAs, genetic variants, and potential drug targets, directly from gene-expression experiments. This unique ability helps researchers quickly zero in on drug targets and validate drug candidates with the greatest potential for success while avoiding costly dead-ends. For more information, please visit

Contact Information

Stacey Sicurella
Public Relations and Brand Manager, Global Marketing

Editorial follow-up
Patrick Farrell
Sniper Public Relations on Behalf of SCIEX


Record changed: 2017-07-02


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

More documents for Danaher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Männer Ballett 650x80px

» top